Company Announcement,
Insider Information: Nexstim Plc’s offering for an
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO
The convertible bond has been subscribed for a total amount of
The complete terms and conditions are attached to this announcement as Annex 1.
Further information is available on the website www.nexstim.com, or by contacting:
+358 50 326 4101
mikko.karvinen@nexstim.com
The Company’s Certified Advisor is
About
Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS System 5 is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in
For more information, please visit www.nexstim.com
Forward-Looking Statements
This company announcement contains forward-looking statements, including, without limitation, statements regarding Nexstim’s strategy, business plans and focus. The words “may”, “will”, “could”, “would”, “should”, “expect”, “plan”, “anticipate”, “intend”, believe”, “estimate”, “predict”, “project”, “potential”, “continue”, “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this announcement are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this announcement, including, without limitation, any related to Nexstim’s business, operations, supply chain, strategy, goals and anticipated timelines, competition from other companies, and other risks described in the Report of the Board of Directors and Financial Statements for the year ended on
Attachments
- Nexstim Plc_Company announcement 2_25 June 2024_FINAL_EN
- Annex 1_Convertible Loan 24062024 - FINAL
![](https://ml-eu.globenewswire.com/media/MDFmMzE5ZGEtNjY5MS00YTI1LThhYzEtYjBlYTBiNmJmYjMyLTEwMjc3Nzk=/tiny/Nexstim-Oyj.png)
© OMX, source